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A reanalysis of the Pliofilm cohort was conducted incorporating six additional years of follow-up
information gathered by the National Institute of Occupational Safety and Health (NIOSH) and a
new set of exposure estimates developed recently. The distribution of individual worker
exposures calculated with the Paustenbach exposure estimates was compared to those derived
using two earlier sets of job-, plant-, and year-specific exposure estimates. A traditional
standardized mortality ratio analysis and the Cox proportional hazards model were used to
investigate the impact of these exposure estimates and the NIOSH updated information on
evaluation of benzene's leukemogenicity. There were no additional cases of multiple myeloma or
any indication of increased incidences of solid tumors. The data added in the update did not
greatly modify the estimated relative risk of all leukemias associated with benzene exposure but
confirmed previous findings that occupational exposure only to very high concentrations had
leukemogenic potential. Leukemia has not been observed in anyone who began employment in
Pliofilm production after 1950. Neither the Paustenbach nor the Crump exposures gave
dose-response estimates as steep as that resulting from the Rinsky exposures. Environ
Health Perspect 104(Suppl 6):1431-1436 (1996)
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Introduction
The Pliofilm rubberworker cohort has been
central to setting health-based standards for
benzene, such as the U.S. Environmental
Protection Agency's (U.S. EPA) cancer
potency factor, the Occupational Safety
and Health Administration's (OSHA)
permissible exposure limit (PEL), and the
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American Conference of Governmental
Industrial Hygienists' (ACGIH) proposed
threshold limit values (TLVs). The reanaly-
sis summarized here from more detailed
accounts (1,2) was motivated by the avail-
ability of new information on two aspects
of the cohort's experience. The National
Institute of Occupational Safety and
Health (NIOSH) had gathered six addi-
tional years of observation on the vital
status of the more highly exposed portion
ofthe cohort. The two existing sets ofjob-,
plant-, and year-specific exposure estimates
were supplemented by a third.
The detailed work histories ofthe indi-
vidual workers composing the Pliofilm
cohort represent a unique resource for esti-
mating the dose response for leukemia that
may follow occupational exposure to ben-
zene. Detailed records ofspecific jobs per-
formed at particular times within the
Pliofilm plants were maintained for all
workers. Although industrial hygiene data
were gathered only intermittently, this
information represents a better basis for
estimation ofindividuals' exposures than is
available for most industrial situations.
Rinsky et al. (unpublished data) and
Crump and Allen (unpublished data)
derived sets of exposure estimates corre-
sponding to specific jobs performed at the
Akron and St. Marys, Ohio, plants over the
years of Pliofilm production. Paustenbach
et al. (3) developed a third and more
refined set of exposure estimates by per-
forming a detailed historical reconstruction
of the industrial practices at the Pliofilm
plants. The cumulative exposure estimates
derived by applying the new exposure esti-
mates to the individual workers' job histo-
ries are compared here with those obtained
using previously reported exposure esti-
mates (Rinsky et al., unpublished data;
Crump andAllen, unpublished data).
The results of NIOSH's monitoring
the vital status of workers from these
Goodyear plants through 1981 were pub-
lished in 1987 (4). NIOSH extended its
follow-up of this cohort for an additional
six years from 31 December 1981 to 31
December 1987. With the last "first expo-
sure" in 1965 and follow-up through
1987, at least 22 years have elapsed since
the most recent possible "first exposure" of
a worker; a sufficient latency period has
passed for assessment ofleukemogenicity.
The impact ofthis update on mortality risk,
especially from leukemia, following occupa-
tional exposure to benzene is presented in
the form ofresults ofstandardized mortality
ratios (SMR) and dose-response analyses.
The proportional hazards model was used in
the dose-response analysis to extend the
conditional logistic analysis by Rinsky et al.
(4) of the then-identified nine leukemia
cases each matched to ten controls.
Standardized Mortality Ratios
in Updated Cohort
The Pliofilm cohort consists of 1868 non-
salaried individuals employed by Goodyear
in the production of Pliofilm (Table 1,
top). In Akron, 824 people worked on this
process at two facilities that operated from
1936 until 1949 and from 1949 until
1965. Another 1044 people were employed
Table 1. Composition of Pliofilm cohort.
Plant location
Job classification St. Marys Akron Total
Allocation of all Pliofilm workers
Wetside 700 591 1291
Dryside 344 233 577
Total 1044 824 1868a
Allocation of white male Pliofilm workers
Wetside 655 557 1212b
Dryside 303 202 505
Total 958 759 1717
aEligible for inclusion in proportional hazards analysis.
bSubjects of standardized mortality ratio analyses.
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in the production ofPliofilm in St. Marys,
from 1940 until 1975. The terms "wet-
side" and "dryside" have been used to parti-
tion the Pliofilm cohort qualitatively into
two groups: 1291 wetside workers were
involved in "precasting" steps ofthe Pliofilm
process involving direct benzene exposure
and 577 dryside workers were engaged in
activities in the Pliofilm process originally
thought not to involve direct benzene expo-
sure. Rinsky et al. (4) did not include the
dryside workers in their SMR calculations
and NIOSH did not pursue follow-up of
these workers in the most recent update
period through 1987, so those workers are
not included in our SMR calculations.
Although a female leukemia case was found
in the update, women have been excluded
from our SMR analyses because there were
too few to allow calculation ofstable esti-
mates. This left 1212 subjects (Table 1,
bottom) for computation of SMRs using
the NIOSH (5) life table program.
NIOSH's update of the vital status of
the wetside Pliofilm workers from 1981 to
1987 identified 123 additional deaths for a
total of 481 deaths in the wetside sub-
group. Table 2 delineates the changes in
SMRs between the two data-gathering
periods for various causes of death. The
SMR for overall mortality was approxi-
mately 1 in both periods. Previously, ben-
zene exposure was associated with an
increase in nonmalignant blood disorders
in this cohort; such end points are not
likely to have lengthy latencies, and no new
cases were reported in the 1987 update.
For all types ofcancer, the SMR remained
nonsignificant. There were no new deaths
from multiple myeloma in the 1987
update, and Wong (6) has determined that
the updated SMR for multiple myeloma of
2.91, with a 95% confidence interval (CI)
of 0.79 to 7.45, is no longer significant.
The addition of five new deaths from
leukemia and one from lymphoma left the
SMR for all lymphatic and hematopoietic
cancers in males little altered and still sig-
nificant. For other types of cancer com-
bined, the SMR remained less than 1.
Animal studies (7) have suggested that
benzene might produce solid tumors in
humans, but no individual type of solid
tumor showed a significant increase.
Descriptions ofthe old and new cases of
lymphatic and hematopoietic cancer are pre-
sented in Table 3, including the first female
(case 21) in the Pliofilm cohort with this
form ofcancer (specifically, an acute myeloid
leukemia). As before, the new leukemia cases
represented a variety ofhistologic types;
unfortunately, the exact type was not speci-
fied for two ofthe new leukemias and this
information is not readily retrievable. Note
that all ofthe cases had held jobs exposing
them to benzene by 1950.
Table 4 compares the SMRs for
leukemia from the old and new updates by
plant location. For the analysis through
1981, the SMR for the overall cohort was
significantly elevated, but the SMR for St.
Marys alone was not. After the update
through 1987, the addition of five new
male leukemia cases increased the SMR for
both locations combined, from 3.15 to
3.60. The addition of two more cases in
Akron had little impact on the SMR, but
the addition of three cases in St. Marys
increased the SMR to 3.36, making it sta-
tistically significant (p<0.05).
Table 5, which gives the SMRs accord-
ing to year of first Pliofilm job, shows no
leukemia cases among the 299 workers
who started in 1951 or later. The leukemia
risk was elevated, but nonsignificant for
those starting Pliofilm work between 1946
and 1950. Leukemia risk was significantly
elevated only for those who started work
prior to the end ofWorld War II. In that
benzene exposures in the Pliofilm process
were markedly and progressively reduced
after World War II, these observations are
consistent with a threshold mechanism for
leukemogenesis induced by benzene but
might also be attributed to the low statisti-
cal power ofthe epidemiology data for this
exposure group.
Individual Worker Exposures
from Three Sets of Exposure
Estimates
For each worker, estimates of cumulative
exposure in ppm-years were generated
using three sets ofexposure estimates corre-
sponding to the occupational codes in the
individual work histories. The original
matrix of exposure estimates (the Rinsky
exposure estimates) was presented in a 1985
draft (Rinsky et al., unpublished data) and
used again but not presented in 1987 (4).
Crump and Allen (unpublished data) devel-
oped another set ofestimates (the Crump
exposure estimates) based on the concept
that the benzene levels in the workplace
probably improved in parallel with pro-
gressively more restrictive standards for
occupational exposure. Using more
detailed information about the monitoring
devices used at the plants, the varying
Table 2. Summary of changes in standardized mortality ratios with update.a
Update of status through
1981 1987
Observed Expected SMR 95% Cl Observed Expected SMR 95% Cl
Cause of death 358 352.22 1.02 0.91-1.13 481 468.22 1.03 0.94-1.12
Noncancer
Nonmalignant diseases of blood and 4 0.86 4.65b 1.27-11.90 4 1.21 3.31 0.90-8.47
blood-forming organs
Cancer 72 70.88 1.02 0.79-1.28 111 102.57 1.08 0.89-1.30
Lymphatic and hematopoietic cancers 15 6.93 2.16b 1.21-3.57 21 9.51 2.21b 1.37-3.38
9 leukemias 14 leukemias
4 multiple myelomas 4 multiple myelomas
2 others 3 others
Other cancers 57 63.95 0.89 0.68-1.17 90 93.06 0.97 0.78-1.20
Buccal cavity and pharynx 2 2.31 0.87 0.10-3.13 3 3.07 0.98 0.20-2.86
Digestive organs and peritoneum 14 19.61 0.71 0.39-1.20 21 27.37 0.77 0.47-1.17
Respiratory system 20 24.78 0.81 0.49-1.25 35 37.31 0.94 0.65-1.30
Male genital organs 7 4.44 1.58 0.63-3.25 9 7.08 1.27 0.58-2.41
Urinary organs 2 3.74 0.53 0.06-1.93 6 5.33 1.13 0.41-2.45
Other and unspecified sites 12 8.96 1.34 0.69-2.34 16 12.76 1.25 0.72-2.04
an=l212 white male wetsideworkers; person-years start accumulating on 1/1/40. bp-Value <0.05 bytwo-sided Poisson test.
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Table 3. Lymphatic and hematopoietic cancers in the Pliofilm cohort.
First benzene Lastbenzene
Case no. Plant location exposure exposure Yearofdeath Age atdeath ICLJ code Cause ofdeath
Inold cohortb
:St. Mes 1940 19.4;;i2 1:56 3. 2042 Mono!c leukemia
2 St. Marys 1948 1948 1950 29 204.1 Chronicmyelogenous leukemia
3 Akon1 204.3 Acute:-oic- leuk
4 Akron 1944 1958 1960 65 204.3 Acutemyelogenous leukemia
5 Akron- 1 1960 1951 82 294.3 to acute m-:y:-cytic leuk:emia
6 Akron 1941 1961 1961 57 204.3 Acutegranulocytic leukemia
7 A'kro' 1942 184 1957 57 2. A!ue i leukemia
8 St. Marys 1950 1952 1954 28 204.1 Myelogenous leukemia
9 Akron1942 1960 1979 67 20511 Acute myol~~~~~~~~~~~~~4.oblticlCeukeamia 9 Akra: ::: XS l
10 St. Marys 1954 1954 1980 69 203 Multiplemyeloma
11t~ ~ ~ ~ ~~~~~~~~~~~~~~~~~~~4 Mt --" -:-- --$-:: ---- ; :;--: @-:-U: - 3 --m I 'i~St'Mm"s 14 94 935 203 Mutp emyloma
12C St. Marys 1943 1968 1968 62 203 Plasmacell sarcoma
:m 13c StMeioys 1954 1955 1961 :1 203 Multiple,ylm
14d St. Marys 1937 1970 1973 64 200.0 Reticulosarcoma
15 4S.Mars 99 Oth malignantneopla;m of m lymphoid or
histiocytictissue
Added in update
16 Akron: :- 1951) --1 957-:---: - - 19-::-:-84 7 ;205.1 Chronic mymoidleukemia
17 Akron 1948 1958 1985 67 205.0 Acutemyeloid leukemia
18 St Mrys :194 -:. :: 13581985 204 Acte : - ly-phoid leukemia
19 St.Marys 1945 1946 1986 71 208.9 Unspecified leukemia
20 a. 19 1 1 8 2 ifiedieukemia
218 Akron 1943 1945 1974 82 205.0 Acute myeloid leukemia
Akron 1947 1941 19~~~~~~~~~~~~~~7 81 202~~~~~.8 Other lyhoa 22d *t.... ...:.;. :t r::
aIntemational Classification ofDiseases code currently on 1987 update of NIOSH tape. bRinsky et al. (4). cThe four cases with ICD Code of 203 (multiple myeloma and
immunoproliferative neoplasms) were not considered in further analyses. dThe three cases of hematopoietic/lymphatic cancers other than leukemia, multiple myeloma, or
plasma cell sarcoma were not considered in further analyses. OThis one female leukemia case was not considered in the SMR analyses but was included in the
dose-response analysis using the proportional hazards model.
length ofthe workweek over the years, the
effect ofWorld War II upon production,
engineering controls, dermal uptake of
benzene, and medical evidence that instances
ofveryhigh level exposure did occur at these
plants, Paustenbach et al. (3) derived a third
matrix ofbenzene exposure estimates (the
Paustenbach exposure estimates). The
Paustenbach exposure estimates are "expo-
sure equivalents" that are normalized to a
40-hr workweek and incorporate dermal,
as well as inhalation, contributions; they
were not designed to equate to real-time
ambient measurements in the plants.
Because of the comprehensiveness and
detail oftheir derivation, the Paustenbach
exposure estimates are the most appropriate
for risk assessment purposes.
Figure 1 presents the cumulative distri-
bution functions of individual cumulative
exposure for all male workers at St. Marys
and Akron under each of the three sets of
exposure estimates. The further to the right
a curve lies relative to the other curves in
Figure 1, the higher the overall estimated
exposure. More than 50% ofthe individu-
als have estimated cumulative exposures of
less than 50 ppm-years using all three expo-
sure matrices. The upper tails of these
highly skewed distributions extend orders
Table 4. Standard mortality ratios for leukemia in Pliofilm workersa by update and location.
Location Update through Person-yearsb Observed Expected SMRC 95% Cl
All 1981 35,587 9 2.86 3.15** 1.44-5.98
1987 40,345 14 3.89 3.60** 1.97-6.04
St. Marys 1981 19,945 3 1.26 2.38 0.49-6.95
1987 22,807 6 1.79 3.36* 1.23-7.31
Akron 1981 15,642 6 1.60 3.76* 1.37-8.18
1987 17,538 8 2.10 3.81** 1.64-7.51
"White male wetside workers. bAccumulation of person-years started on 1/1/40 or at the start of the first Pliofilm
job, whichever was later. cp-Values bytwo-sided Poisson test. * p<0.05; ** p<0.01.
Table 5. Standardized mortality ratios for leukemia in Pliofilm workers by date offirst exposure.
Date offirst exposure Person-years Observed Expected SMRC 95% Cl
1945 or before 10,389 9 1.44 6.26** 2.85-11.89
1946-1950 21,165 5 1.72 2.91 0.94-6.81
1951 orafter 8,791 0 0.75 0 0-3.99
aWhite male wetside workers. bAccumulation of person-years started on 1/1/40 or at the start of thefirst Pliofilm
job, whichever was later. cp-Value bytwo-sided Poisson test. ** p<0.01
ofmagnitude above their medians, resulting
in arithmetic averages (Figure 2) that are
about ten times higher than their medians.
The estimated values for the leukemia
cases are superimposed upon each curve in
Figure 1. For St. Marys, the estimates for the
six leukemia cases are spread quite evenly
over the range ofcumulative exposure esti-
mates, but for Akron, the estimates for
almost all the eight leukemia cases are clus-
tered at the upper extreme ofthe exposure
distributions. As indicated under "cause of
death" in Table 3, Akron and St. Marys also
differ in that the leukemia cases in Akron
were predominantly acute myelogenous
leukemias (AMLs), whereas in St. Marys this
was not so. The lack ofa dose response in St.
Marys argues against benzene's being
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leukemias observed in St. Mar)
The individual workers
exposures follow the patte
Paustenbach et al. (3) for th(
estimates: a) the estimates fi
generally higher than those f
b) the Paustenbach estimati
overall than the Crump estir
the latter two sets ofestimate
the Rinsky estimates. The thri
exposure estimates for a parti
ual may deviate from general
As shown in Figure 2, the CGr
estimates give a lower mean
controls than do the Paustent
estimates. At St. Marys, howe
Table 6. Standardized mortality ratios for leukemia in Pliofilm workersa by cumulative exposure at all locations.
Cumulative
Exposure exposure,
estimates ppm-years Person-years Observed Expected SMRb 95% Cl
Rinsky 0-5 18,178 3 1.52 1.97 0.41-5.76
::) :A 3: 1:,; . 1 .2.9 0.74.69
>50-500 8,383 7 1.01 6.93** 2.78-14.28
:50 32:8 : 1 0.5 20.00 : 0.5t-111.4
Crump 0-5 12,974 1 1.14 0.88 0.02-4.89
:::::5t 1 4 1.2
>50-500 11,448 6 1.23 4.87* 1.79-10.63
500 ......,90.29 1.13-3972 . . ... .2 ..
Paustenbach 0-5 9,645 1 0.75 1.33 0.03-7.43
O1 2 1 4
>50-500 14,095 4 1.43 2.80 0.76-7.16 *_._._:..................................7.::.,.........:.,.
0 3m723 7etside wrr. b0.059 **:1.27 4.76-2 4
"White male wetside workers. bp..Value by two-sided Poisson test: *p<0.05, **p<0.01.
Pr cumulative exposure for the cases using the
Crump exposure estimates is greater than
that derived using the Paustenbach esti-
mates, and the Paustenbach estimates actu-
ally give lower estimated average exposure
for the cases than for the controls. This devi-
ation from the absolute increase that might
have been expected with the Paustenbach
10 1000 10o06 exposure estimates lends credence to the
ppm-years objectivity and validity ofthe Paustenbach
industrial hygiene reconstruction. One as In relation to could view the Paustenbach and the Crump
exposure estimates as beingmutually confir-
matory in that the results of Paustenbach's
detailed reconstruction lend support to the
validity ofthe simple assumption that was
L the basis for the Crump exposure estimates.
Using the three sets of cumulative
exposure estimates, SMRs and confidence
intervals were derived for the person-years
._ m at risk in the categories: 0 to 5, 5 to 50, 50
Cases Controls to 500, and more than 500 ppm-years
Akron (Table 6). These findings suggest a strong dose-response relationship of risk increas-
tive exposures of ing with cumulative exposure no matter
which set ofexposure estimates is used. For
none ofthe three sets ofexposure estimates,
iology of the however, is there a statistically significant
ys. increase in the SMRs for cumulative expo-
cumulative sures less than 50 ppm-years. This is
rn noted by consistent with the hypothesis that expo-
e job-specific sure in excess ofsome threshold value (here
or Akron are suggested to be greater than 50 ppm-years)
or St. Marys; is necessary for leukemogenesis. This
es are higher threshold hypothesis is further supported
mates; and c) by work at the mechanistic level (8-11).
s both exceed [In a similar analysis of cumulative expo-
ee cumulative sure partitioning these leukemia cases into
cular individ- acute myelocytic or acute monocytic
lities a and b. leukemias (AMMLs) versus non-AMMLs,
imp exposure Crump (12) showed that the dose-
value for the response relationship is driven by AMMLs
)ach exposure with a suggested threshold in excess of400
ver, the mean ppm-years and that the frequency of the
other leukemias is not associated with
benzene exposure.]
Risks Estimated by
Proportional Hazards
Dose-Response Model
Statistical analysis with the proportional
hazards dose-response model (13) relates
exposure to the incidence of leukemia
while controlling for demographic, socio-
economic, and other variables that might
confound interpretation ofthe data. With
this same objective, Rinsky et al. (4) had
used a conditional logistic regression analy-
sis on a subset ofthe Pliofilm data consisting
ofthe nine leukemia cases (all white males),
each ofwhom was matched on the basis of
sex, race, date of birth, and date of first
employment in a Pliofilm job to ten con-
trols who were alive at the time their corre-
sponding case died. Because it accepts all
controls falling within a defined stratum
(Table 7), the proportional hazards analysis
includes more workers than would the con-
ditional logistic's matching process. It does
not require the arbitrary assignment ofeach
control to one ofseveral cases sharing simi-
lar profiles or the utilization ofvery poorly
matched controls when the fixed number of
appropriate individuals is not available, as
does the conditional logistic analysis.
The matching criteria of Rinsky et al.
(4) were used to define the strata in the
proportional hazards model (i.e., sex, race,
date ofbirth, and date offirst Pliofilm job).
The possibility that the plants in Akron and
St. Marys might have differed in the leu-
kemogenic response they induced because
offactors other than benzene exposure lev-
els was controlled for by using location as
an additional matching criterion. Although
the vital status of the dryside workers had
been followed up only through 1981, they
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Table 7. Composition of strata analyzed with proportional hazards model for update through 1987.
Decade offirst Number in stratum
Stratum Location Sexa Decade ofbirth Pliofimemployment Cases Controls
St. Marys Male 1900-1909 1940-1949 1 2
St. Marys Male 1920-1929 1940-1949 2 305
Ma 19.
Akron Male 1886-1895 1936-1945 1 18
..:- *1e. : ..... .1*1s- . ................ : 1 * | " . --: --. ........................:..... r on Male -4
Akron Male 1906-1915 1936-1945 1 27
4i
Akron Female 1886-1895 1936-1945 1 7
0.......;'...:.650
aNonblack wetside and dryside cohort members alive at the time of a case's death were eligible for
matching to the cases, who were all white.
made suitable stratum co-occupants in the
proportional hazards model for leukemia
cases based on age calculations up to 1981.
A female leukemia patient identified dur-
ing the 1987 update was included in our
proportional hazards analysis because she
could be appropriately matched with female
controls in a separate stratum. Therefore, all
1868 Pliofilm workers were considered eli-
gible for inclusion in this proportional haz-
ards analysis (Table 1, top) using BMDP
software (Bio-Medical Data Processing,
Los Angeles, CA) (14).
To estimate the probability ofleukemia
over a lifetime associated with various
cumulative exposures (x,) to benzene, we
usedi(0) the estimate ofbackground life-
time (t = 70) leukemia probability derived
(15) as a reference point and get
P(X70)
= (0)RR(70;x)
The increase in risk for a cumulative
benzene exposure of x70 was estimated as
p(X70) -0(o)-
Table 7 describes the composition of
the informative strata used in regression
analysis based on the proportional hazards
dose-response model for the cohort as
updated through 1987. Our proportional
hazards analysis used 665 (35.6%) of the
1868 members ofthe entire Pliofilm cohort
compared to the 165 (8.8%) that would
have been used if the conditional logistic
approach of Rinsky et al. (4) had been
applied to the 15 leukemia cases found
through 1987.
The estimates of the slope parameter
in this dose-response model before and
after the 1987 update under the three sets
of exposure estimates are presented in
Table 8. For either update period, the
slope of dose-response relationship was
estimated to be about 20 to 40% as steep
using the Crump or the Paustenbach esti-
mates of exposure as when the Rinsky
exposure estimates were used. Updating
the cohort's leukemia status through 1987
resulted in a lowering of the estimated
slope parameters under all three sets of
exposure estimates.
The predictions ofadditional leukemia
deaths and associated 95% confidence
intervals are plotted in Figure 3. Risks for
occupational exposure are given for work-
ing lifetimes (8 hr/day, 5 days/week, 50
weeks/year for 45 years) for continuous
exposure at 0.1, 0.3, 1, 5, or 10 ppm. In
the current analysis, using the preferred
exposure estimates of either Crump or
Paustenbach predicts about 0.3 to 0.5
additional leukemia deaths per thousand
workers in the concentration range around
1 ppm. Overall, the results of this update
and reanalysis suggest that the previous
estimate of 5.1 additional leukemia deaths
for that exposure scenario [(16), based on
the approach ofRinsky et al. (4)], is about
an order of magnitude too high. More
detailed investigation ofthe dose-response
relationships in the Pliofilm cohort using
all the workers and focusing on the most
pertinent end point, AMLs only, may be
found in the sensitivity analysis of Crump
(12) summarized at this conference.
ioo - * Rinsky
Crump
= 10 -* Paustenbach
0.1
0
W.1 0.3 1 5 10
Occupational benzene exposure (ppm)
for a 45-yearworking lifetime
Figure 3. Additional leukemia deaths estimated by the
proportional hazards model and earlier analyses.
Conclusion
The additional information assembled in
updating the Pliofilm cohort strengthens
but does not greatly alter the thrust of the
data through 1981 concerning leukemia
risk in this occupational setting (4,16). The
absence of any additional cases ofmultiple
myeloma in the update through 1987
weakens to nonsignificance the previous
statistical association ofthis end point with
benzene exposure. There continues to be
no evidence of any increase in the inci-
dence of any type of solid tumors. The
more rigorously defined exposure esti-
mates derived by Paustenbach et al. (3) are
consistent with those of Crump and Allen
(unpublished data) in giving estimates ofthe
slope of the leukemogenic dose response
that are not as steep as the slope resulting
from the exposure estimates ofRinsky et al.
(unpublished data).
The newly gathered information con-
tinues to be consistent with a threshold
model for leukemogenesis by benzene. The
leukemia deaths in the entire cohort
occurred exclusively among individuals
who commenced their work in Pliofilm
production in 1950 or earlier. The simplest
explanation would be that industrial
hygiene improved over the years at both
Akron and St. Marys and achieved a criti-
cal level of reduced benzene exposure in
the early 1950s, so that workers entering
the workplace after that time were no
longer at risk for developing leukemia.
Table8. Proportional hazards estimates ofprobabilityof leukemogenic response as a function ofcumulative exposure.
Updatethrough Exposureestimates pa Standard error p-Value
1981b Rinsky 0.0047 0.0015 0.0002
. ~ : 1099 00094- . . -.;:::: . ..01196
Paustenbach 0.0020 0.0007 0.0008
.... : .. :. ...... ;'
Crump 0.0008 0.0004 0.0602
* . :::.P.:v.te.:.c. 0.2 0::.0005 : :; :::0.005:
,Because the underlying models differ, these Ps are not directly comparable to those derived by Rinsky et al. (4)
and by Brett et al. (16) using the conditional logistic model. bBased upon the original 9 leukemia cases and the
527 controls in their strata. cBased upon the updated information on all 15 leukemia cases and the 650 controls in
their strata.
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